Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 19Prostatic Neoplasms 14Carcinoma, Non-Small-Cell Lung 9Pancreatic Neoplasms 8Neoplasms 8Colorectal Neoplasms 8Melanoma 6Colonic Neoplasms 6Esophageal Neoplasms 5Stomach Neoplasms 4Rectal Neoplasms 4Precancerous Conditions 4Myelodysplastic Syndromes 4Lymphoma 4Lung Neoplasms 4Liver Neoplasms 4Head and Neck Neoplasms 4Barrett Esophagus 4Squamous Cell Carcinoma of Head and Neck 3Salivary Gland Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Multiple Myeloma 3Mouth Neoplasms 3Kidney Neoplasms 3Gastrointestinal Neoplasms 3Gastroesophageal Reflux 3Gastritis, Atrophic 3Adenocarcinoma Of Esophagus 3Uterine Cervical Neoplasms 2

Interventions

Urine Specimen Collection 1Therapeutics 1Steroids 1Propranolol 1Prednisolone 1Observation 1High-Energy Shock Waves 1Hepatectomy 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hemangioma × Biopsy × Clear all
NCT02334930 2016-08-22

PEC-Hem

University Hospital, Bordeaux

Completed
13 enrolled

Hemangioma, Perivascular Epithelioid Cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡